FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and BPC 157 TB 500 Peptide Blend The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Compounded "semaglutide" is not FDA approved semaglutide.com Is BPC 157 Banned? Oral vs. Injectable Forms Explained